Возрастной андрогенный дефицит у мужчин: этиология, клиника, диагностика, лечение
Аннотация
Об авторах
Е. Ю. Пашкова
НУЗ «Научный клинический центр ОАО “РЖД”»; Россия, 125315, Москва, ул. Часовая, 20;
Россия
Россия
О. А. Рождественская
кафедра эндокринологии и диабетологии ГБОУ ДПО «Российская медицинская академия последипломного образования» Минздрава России; Россия, 125993, Москва, ул. Баррикадная, 2/1
Россия
Россия
Список литературы
1. Bhasin S., Buckwater J.G. Testosterone supplementation in older men: a rational idea whose time has not yet come. J Androl 2001;22(5):718–31.
2. Feldman H.A., Longcope C., Derby C.A. et al. Age trends in the level of serum testosterone and other hormones in middleaged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002;87(2):589–98.
3. Harman S.M., Metter E.J., Tobin J.D. et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86(2):724–31.
4. Mitchell R., Hollis S., Rothwell C., Robertson W.R. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clin Endocrinol (Oxf) 1995;42(5):501–7.
5. Wu F.C., Tajar A., Pye S.R. et al. Hypothalamic-pituitary-testicular axis disruptions in older man are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008;93(7):2737–45.
6. Wang C., Nieschlag E., Swerdloff R. et al.; International Society of Andrology; International Society for the Study of Aging Male; European Association of Urology; European Academy of Andrology; American Society of Andrology. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur Urol 2009;55(1):121–30.
7. Gray A., Berlin J.A., McKinlay J.B., Longcope C. An examination of research design effects on the association of testosterone and male aging: results of meta-analysis. J Clin Epidemiol 1991;44(7):671–84.
8. Gray A., Feldman H.A., McKinlay J.B., Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73(5):1016–25.
9. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26(6):833–76.
10. Nieschlag E., Behre H., Nieschlag S. Testosterone: action, deficiency, substitution. Cambridge: Cambridge University Press, 2004.
11. Bross B., Javanbahkit M., Bhasin S. Anabolic interventions for agingassociated sarcopenia. J Clin Endocrinol Metab 1999;84(10):3420–30.
12. Wu F.C., Tajar A., Beynon J.M. et al.; EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363(2):123–35.
13. Khat K.T., Barret-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol 1992;2(5):675–82.
14. Ringe J., Dorst A. Osteoporose bei Mannern. Dtsch Med Wochenschr 1994;119:943–7.
15. Tracz M.J., Sideras K., Boloña E.R. et al. Testosterone use in men and its effects on bone health. A systematic review and metaanalysis of randomized placebo-controlled trials. J Clin Endocrinol Metab 2006;91(6):2011–6.
16. Jockenhovel F. Male hypogonadism. Practical aspect of androgen therapy. Bremen: Uni-Med Verga, 2004. Pp. 117–34.
17. Morgentaler A. Male impotence. Lancet 1999;354(9191):1713–8.
18. Jain P., Rademaker A.W., McVary K.T. Testosterone supplementation for erectile dysfunction: results of meta-analysis. J Urol 2000;164(2):371–5.
19. Kalinchenko S.Y., Kozlov G.I., Gontcharov N.P., Katsiya G.V. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male 2003;6(2):94–9.
20. Lakshman K.M., Basaria S. Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Clin Interv Aging 2009;4:397–412.
21. Boyanov M.A., Boneva Z., Christov V.G. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003;6(1):1–7.
22. Moffat A.D., Zonderman A.B., Metter E.J. et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002;87(11):5001–7.
23. Alexander J.M. Swerdloff R.S., Wang C. et al. Androgen-behavior correlations in hypogonadal men and eugonadal men. I. Mood and response to auditory sexual stimuli. Horm Behav 1997;31(2):110–9.
24. Jockenovel F., Gerhardts S. Erkrankungen von hypotalamus und hypophyse. Bremen: Uni-Med Verlag, 2002.
25. Isidori A.M., Giannetta E., Greco E.A. et al. Effects of testosterone on body composition, body metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005;63(3):280–93.
26. Kapoor D., Goodwin E., Channer K.S., Jones T.H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006;154(6):899–906.
27. Stattin P., Lumme S., Tenkanen L. et al. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004;108(3):418–24.
28. Fernández-Balsells M.M., Murad M.H., Lane M. et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95(6):2560–75.
29. Haddad R.M., Kennedy C.C., Caples S.M. et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebocontrolled trials. Mayo Clin Proc 2007;82(1):29–39.
30. Saad F., Aversa A., Isidori A.M. et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011;165(5):675–85.
31. Еuropean Association of Urology Guidelines 2014. Pp. 788–815.
Рецензия
Для цитирования:
Пашкова Е.Ю., Рождественская О.А. Возрастной андрогенный дефицит у мужчин: этиология, клиника, диагностика, лечение. Андрология и генитальная хирургия. 2015;16(1):95-101. https://doi.org/10.17650/2070-9781-2015-1-95-101
For citation:
Pashkova E.Yu., Rozhdestvenskaya O.A. Late-onset hypogonadism: etiology, clinical features, diagnostics, treatment. Andrology and Genital Surgery. 2015;16(1):95-101. (In Russ.) https://doi.org/10.17650/2070-9781-2015-1-95-101
Просмотров: 1312
Послать статью по эл. почте 